Company
A Cornell spinout, built by clinicians.
Solliva was founded by a Yale- and Weill Cornell-trained neurologist (MD, PhD), and validated with the people who will use it before a single line of marketing copy was written.
Validated before it shipped
40+
structured stakeholder interviews
Physicians, patients, and health system leaders, through NSF I-Corps.
10
independent physicians
Rated Solliva's summaries blind against physician-written ones.
Sept 2025
provisional patent filed
Following a favorable prior art search.
Cornell
spinout
Founded by a Yale- and Weill Cornell-trained neurologist (MD, PhD).
Built for HIPAA-compliant deployment, with consent-first onboarding per Care Center/Clinic. Solliva does not diagnose or prescribe, and all clinical decisions remain with the treating provider.